Hemostatic Agents Market to reach US$ 5,441.5 Mn by 2025, at a CAGR of 6.4% | Exclusive Report by Fortune Business Insights

Ads

You May Also Like

TESARO Announces Participation in Two Investor Conferences

WALTHAM, Mass., May 01, 2018 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical ...

Orion Biotechnology Canada Acquires K2Biomedical

OTTAWA, June 14, 2018 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd., a developer of ...